Article
[Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications].
Annales de pathologie - 1 Apr 2020
Koual Meriem, Perkins Géraldine, Delanoy Nicolas, Crespel Céline, Medioni Jacques, Nguyen-Xuan Huyên-Thu, Douay-Hauser Nathalie, Blons Hélène, Le Frère-Belda Marie-Aude, Molière Diane, Achen Guillaume, Nos Claude, Balaya Vincent, Montero Rosa, Laurent-Puig Pierre, Bats Anne-Sophie
Abstract excerpt
Patients who carry the BReast Cancer 1 or 2 (BRCA) gene mutations have an underlying hereditary predisposition for breast and ovarian cancers. These deleterious genetic mutations are the most common ones implicated in hereditary breast and ovarian cancers. Oncogenetic counselling plays a key role in identifying patient for BRCA testing and for mutation identification. BRCA1/2 carriers have to be followed up...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.